Insider Trading & Ownership - Ocumension Therapeutics

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Ocumension Therapeutics
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-01-11
Sale
2024-01-16
6:55 pm
EyePoint Pharmaceuticals Inc.EYEPOcumension Therapeutics
Director
1,910,500$19.45$37,159,225100,221
(Direct)
View
2023-12-05
Sale
2023-12-07
9:21 pm
EyePoint Pharmaceuticals Inc.EYEPOcumension Therapeutics
Director
1,000,000$19.51$19,510,6372,010,721
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing

Ownership
2021-04-30
1:18 pm
N/A
N/A
ALIMERA SCIENCES INCALIMOcumension Therapeutics
10% Owner
0$01,144,945
(Direct)
View

Ownership
2021-01-14
08:07 am
N/A
N/A
EyePoint Pharmaceuticals Inc.EYPTOcuMension Therapeutics
10% Owner
0$03,010,722
(Direct)
View